Harrow (HROW) Net Cash Flow (QoQ) (2010 - 2026)
Harrow (HROW) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 50.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -149.52% |
| Mar 31, 2026 | 1,693.32% |
| Dec 31, 2025 | -106.39% |
| Sep 30, 2025 | 254.96% |
| Jun 30, 2025 | -170.66% |
| Mar 31, 2025 | 176.83% |
| Dec 31, 2024 | -1,652.60% |
| Sep 30, 2024 | -32.80% |
| Jun 30, 2024 | 143.81% |
| Mar 31, 2024 | -165.45% |
| Dec 31, 2023 | -80.22% |
| Sep 30, 2023 | 1,122.36% |
| Jun 30, 2023 | 104.55% |
| Mar 31, 2023 | -250.11% |
| Dec 31, 2022 | 3,569.30% |
| Sep 30, 2022 | -132.94% |
| Jun 30, 2022 | 2,150.23% |
| Mar 31, 2022 | 98.60% |
| Dec 31, 2021 | -4.63% |
| Sep 30, 2021 | -122.60% |